142 related articles for article (PubMed ID: 3138097)
1. New H2-blockers: does more choice help?
Drug Ther Bull; 1988 Aug; 26(17):65-6. PubMed ID: 3138097
[No Abstract] [Full Text] [Related]
2. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
De Natale G; De Natale F; Marino A
Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
[TBL] [Abstract][Full Text] [Related]
3. Clinical importance of the new H2-antagonists.
Walt RP
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():97-9. PubMed ID: 2566730
[TBL] [Abstract][Full Text] [Related]
4. [Peptic ulcer. New H2 blockers, prostaglandins, benzimidazoles].
Gugler R
Fortschr Med; 1987 Apr; 105(10):197-201. PubMed ID: 3108126
[No Abstract] [Full Text] [Related]
5. Peptic ulceration.
Weir DG
Br Med J (Clin Res Ed); 1988 Jan; 296(6616):195-200. PubMed ID: 2892567
[No Abstract] [Full Text] [Related]
6. Famotidine: clinical applications of a new H2-receptor antagonist. May 16, 1986, Carmel, California.
Am J Med; 1986 Oct; 81(4B):1-64. PubMed ID: 2877568
[No Abstract] [Full Text] [Related]
7. [H2 receptor antagonists and intragastric acidity].
Dammann HG; Walter TA; Müller P; Simon B
Dtsch Med Wochenschr; 1984 Nov; 109(46):1767-9. PubMed ID: 6094136
[No Abstract] [Full Text] [Related]
8. Healing and relapse rates of duodenal ulcer with various H2 receptor antagonists.
Ahmed W; Qureshi H; Zuberi SJ
J Pak Med Assoc; 1988 Dec; 38(12):319-22. PubMed ID: 3148760
[No Abstract] [Full Text] [Related]
9. Ranitidine in cimetidine-resistant ulcers.
Seligman M; Schneiweiss F
Drug Intell Clin Pharm; 1983 Sep; 17(9):629-30. PubMed ID: 6311504
[No Abstract] [Full Text] [Related]
10. [New developments in ulcer therapy: famotidine, omeprazole misoprostol].
Gugler R
Med Klin (Munich); 1986 Mar; 81(6):208-13. PubMed ID: 3097476
[No Abstract] [Full Text] [Related]
11. Medical management of acute peptic ulcer disease.
Karras PJ; Schulze KS
Iowa Med; 1986 Jul; 76(7):326-7, 330. PubMed ID: 3755707
[No Abstract] [Full Text] [Related]
12. Frequent non-response to histamine H2-receptor antagonists in cirrhotics.
Walker S; Krishna DR; Klotz U; Bode JC
Gut; 1989 Aug; 30(8):1105-9. PubMed ID: 2570008
[TBL] [Abstract][Full Text] [Related]
13. The clinical use of histamine-2 receptor antagonists.
Michocki RJ; Richardson JP
Md Med J; 1992 May; 41(5):397-400. PubMed ID: 1625532
[TBL] [Abstract][Full Text] [Related]
14. [Famotidine in the therapy and prevention of duodenal ulcer].
Reggio D; Frattaroli FM; Trentino P; Oddi A; Marzullo A; Ponsioen C; Pappalardo G
Clin Ter; 1988 Oct; 127(2):105-11. PubMed ID: 2976345
[No Abstract] [Full Text] [Related]
15. [Evaluation of a combination of colloidal bismuth and pirenzepine in duodenal ulcer in non-responders to anti-H2 receptors].
Manca A; Ferraris R; Ghezzo L; Asnaghi G; Ferro GF
Minerva Dietol Gastroenterol; 1988; 34(2):135-8. PubMed ID: 3173756
[No Abstract] [Full Text] [Related]
16. Pharmacologic options for the control of peptic ulcer disease.
Levine JB
Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
[No Abstract] [Full Text] [Related]
17. [Controversies on the drug treatment of peptic ulcer].
Mincis M
Rev Paul Med; 1984; 102(3):122-4. PubMed ID: 6089298
[No Abstract] [Full Text] [Related]
18. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
19. Sucralfate for peptic ulcer--a reappraisal.
Med Lett Drugs Ther; 1984 Apr; 26(660):43-4. PubMed ID: 6323938
[No Abstract] [Full Text] [Related]
20. Famotidine in the short-term treatment of duodenal ulcer and of concomitant peptic lesions: comparison with cimetidine.
Polloni A; Marchi S; Greco A; Cipparrone G; Costa F; Bellini M; Maltinti G
Int J Clin Pharmacol Res; 1988; 8(2):139-42. PubMed ID: 3378855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
